Clinical Trial Update: Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) [Phase 1]

View source ↗

Summary

Phase 1 study of SCH 900776 (MK-8776) with and without cytarabine in acute leukemias; the trial is terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Aggressive Phase Myelogenous Leukemia
• Philadelphia-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• SCH 900776 (MK-8776) (SCH 900776)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Myelogenous Leukemia, Acute, Leukemia, Lymphocytic, Acute | Phase 1 | Status: TERMINATED | Results posted: 2017-01-25